Hypoparathyroidism in Denmark (HypoPT)
This study has been completed.
Information provided by (Responsible Party):
University of Aarhus
First received: December 20, 2011
Last updated: June 30, 2014
Last verified: January 2013
The purpose of this study is to identify the number of persons in Denmark with the diagnose hypoparathyroidism, autosomal dominant hypocalcaemia or pseudohypoparathyroidism. Also the investigators want to identify the causes and symptoms of these patients and their prognosis.
||Hypoparathyroidism, Autosomal Dominant Hypocalcaemia and Pseudohypoparathyroidism in Denmark - Epidemiology, Causes, Symptoms and Prognoses
Biospecimen Retention: None Retained
Primary Outcome Measures:
- Frequency of hypoparathyroidism, pseudohypoparathyroidism and autosomal dominant hypocalcaemia and its consequences [ Time Frame: One year ] [ Designated as safety issue: No ]
The frequency of hypoparathyroidism, pseudohypoparathyroidism and autosomal dominant hypocalcaemia. The frequence is estimated via the National Danish Health Register.
The prevalence of kidney-, cardiovascular- and neuropsychiatric disease, fertility, hospitalization required hypo- or hypercalcaemia, overall number of hospitalizations and mortality.
2 designs: Case-finding; Case-control
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||May 2012 (Final data collection date for primary outcome measure)
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
The study population are persons with hypoparathyroidism, automalt dominant hypocalcaemia and pseudohypoparathyroidism.
The population is selected via the National Danish Health Registre and the Danish Medical Registre
Inclusion Criteria for the case-control-study:
- Idiopathic hypoparathyroidism
- Autosomal dominant hypocalcaemia
Exclusion Criteria for the case-control-study:
- Chronic kidney insufficience (creatinine above 200 umol/l)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01498341
|Department of Internal Medicine and Endocrinology, Aarhus University Hospital, Tage-Hansens Gade
|Aarhus, Region Midt, Denmark, 8000 |
University of Aarhus
||Lars Rejnmark, DmSci, PhD
||Aarhus University Hospital
||University of Aarhus
History of Changes
|Other Study ID Numbers:
|Study First Received:
||December 20, 2011
||June 30, 2014
||Denmark: Danish Dataprotection Agency
Denmark: The Regional Committee on Biomedical Research Ethics
Keywords provided by University of Aarhus:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on April 27, 2016
Endocrine System Diseases